Research News and Research

RSS

Compugen 2010 third quarter net loss decreases to $1.6 million from $1.9 million

Compugen Ltd. today reported financial results for the third quarter ending September 30, 2010.

26 Oct 2010

First Edition: October 26, 2010

In today's headlines, more reports from the campaign trail -- highlighting how tempers and politics continue to flare around health overhaul issues.

26 Oct 2010

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

Biogen Idec Inc. a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its third quarter 2010 results.

26 Oct 2010

New findings could deliver low-cost method to extract anticancer compound

A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests. Researchers have isolated and grown stem cells from a yew tree whose bark is a natural source of the anticancer compound paclitaxel. The development could enable the compound to be produced on a commercial scale at low cost, with no harmful by-products.

26 Oct 2010

India's Trade Minister says EU will take steps to prevent seizure of generic medicines

"India believes a row with the European Union over seizures of generic drugs will be settled without litigation, Trade Minister Anand Sharma said on Wednesday," Reuters reports (Lynn, 10/20).

26 Oct 2010

Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million

Kinetic Concepts, Inc. today reported third quarter 2010 total revenue of $506.7 million compared to $504.4 million in the third quarter of 2009 and up 2% from the second quarter of 2010.

26 Oct 2010

Einstein updates Strategic Research Plan

Albert Einstein College of Medicine of Yeshiva University has updated its Strategic Research Plan, the guidepost by which research priorities for the College of Medicine are set and measured. The update is designed to keep Einstein's research enterprise on course, to determine which investigative areas should be expanded or redirected, and to identify new areas that were underappreciated when the original research plan was formulated.

26 Oct 2010

Research indicates stroma tissue provides new drug target for treating pancreatic cancer

A project focusing on the scar tissue surrounding cancer tumours aims to provide new targets for drugs for treating pancreatic cancer, the fifth highest cause of cancer deaths in the UK.

26 Oct 2010

AAHC launches Education and Training Clinical Research Compliance Tool

The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.

26 Oct 2010

Prevention of vascular diseases needed to avoid tsunami of cases

Canada urgently needs to focus on prevention of vascular diseases to avoid the burden from the expected tsunami of cases, says noted stroke expert Dr. Robert Côté, delivering the Heart and Stroke Foundation of Canada (HSFC) Lecture at the Canadian Cardiovascular Congress 2010.

26 Oct 2010

Lumiphore signs global cooperation with Algeta to integrate Lumi4 complexes

Lumiphore Inc., a portfolio company of Nanostart AG, has signed a global cooperation with Algeta ASA a leading company specializing in innovative radiopharmaceutical therapies to treat cancer patients. The agreement enables the integration of Lumiphore's Lumi4 complexes into the targeted radiotherapeutics and companion diagnostics from Algeta.

From Thermo Fisher Scientific Inc. 26 Oct 2010

PAREXEL's white paper provides data on biopharmaceutical, medical device product development

PAREXEL Consulting, a business unit of PAREXEL International and a leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released a new white paper entitled Drug Innovation, Approval, Market Access, and the New Normal Emerging FDA Review Outcome Trends for New Drugs.

From Parexel 26 Oct 2010

Neurologix holds license for gene therapy to treat severe depression

Neurologix, Inc. today announced that a landmark paper, published on October 20th in Science Translational Medicine demonstrating the importance of the p11 gene in modulating depression in mice, utilized a gene therapy approach to reverse depression in mice for which the Company holds exclusive development rights. Based on the findings reported in the paper, gene therapy may have potential as a new treatment option for people who suffer from severe depression.

26 Oct 2010

Researchers find new antibiotic strategies for hibernating bugs

New strategies to apply antibiotics more effectively to hibernating bugs have been developed by researchers at the University of Hertfordshire.

26 Oct 2010

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Techulon™ Inc., an early stage life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new theranostic transfection reagent. This new traceable reagent complements Techulon's currently marketed Glyocofect™ transfection platform and expands the company's offering in an $800 million market that is steadily growing at 15% annually.

26 Oct 2010

Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older

The number of hospital admissions among Americans ages 45 and older for medication and drug-related conditions doubled between 1997 and 2008, according to a new report released today by HHS' Agency for Healthcare Research and Quality. Medication and drug-related conditions include effects of both prescription and over-the-counter medications as well as illicit drugs.

26 Oct 2010

Omeros to develop new drugs for major diseases

The Life Sciences Discovery Fund (LSDF) today announced a $5 million grant to Seattle-based Omeros Corporation (NASDAQ: OMER) to discover, develop, and commercialize new drugs to treat a variety of major diseases. With successful generation of proceeds through partnering and the sales of drugs in the marketplace, an additional outcome of the grant would be establishment of a new non-profit initiative to advance the life sciences sector and improve health and economic growth in Washington state.

26 Oct 2010

Place of birth, low SES and exposure to pests associated with asthma in U.S.-born children

Researchers from Tufts University pooled data from five previous epidemiological studies to investigate the prevalence of asthma in children in the Boston neighborhoods of Chinatown and Dorchester. Among children born in the United States, low socioeconomic status (SES) and exposure to pests (mice and cockroaches) were both associated with having asthma. Neither association was present in children born outside of the United States. The study was published online in advance of print in the Journal of Immigrant and Minority Health.

26 Oct 2010

Researchers identify signaling pathway that promotes metastasis of pediatric bone cancer

Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer. Their research showed that the Notch pathway and Hes1 gene play a key role in promoting the metastasis of osteosarcoma, the most common form of bone cancer in children.

26 Oct 2010

Athletic performance can improve after heat acclimation

Turning up the heat might be the best thing for athletes competing in cool weather, according to a new study by human physiology researchers at the University of Oregon.

26 Oct 2010

Research News and Research

Compugen 2010 third quarter net loss decreases to $1.6 million from $1.9 million

First Edition: October 26, 2010

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

New findings could deliver low-cost method to extract anticancer compound

India's Trade Minister says EU will take steps to prevent seizure of generic medicines

Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million

Einstein updates Strategic Research Plan

Research indicates stroma tissue provides new drug target for treating pancreatic cancer

AAHC launches Education and Training Clinical Research Compliance Tool

Prevention of vascular diseases needed to avoid tsunami of cases

Lumiphore signs global cooperation with Algeta to integrate Lumi4 complexes

PAREXEL's white paper provides data on biopharmaceutical, medical device product development

Neurologix holds license for gene therapy to treat severe depression

Researchers find new antibiotic strategies for hibernating bugs

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Admissions for medication, drug-related conditions increase by 117% among Americans aged 45 and older

Omeros to develop new drugs for major diseases

Place of birth, low SES and exposure to pests associated with asthma in U.S.-born children

Researchers identify signaling pathway that promotes metastasis of pediatric bone cancer

Athletic performance can improve after heat acclimation

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News